Skip to content

Different treatment of children suffering from worms

Individualized homoeopathic medicines versus standard care in treatment of intestinal nematodes in children: A comparative cohort study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051596
Enrollment
100
Registered
2023-04-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B820- Intestinal helminthiasis, unspecified

Interventions

Intervention1: Individualized homeopathic medicines plus concomitant care: Intervention is planned as administering the indicated homoeopathic medicines in centesimal potencies (cH). Each dose will co
dosage and repetition depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking or brushing teeth within
in schoolchildren (6-12 years) and adults (21 years or more) (i) 200 mg (only for hookworm infections), (ii) 400 mg, (iii) 600 mg and (iv) 800 mg. Advice will be given to maintain proper hygiene, e.g.

Sponsors

D N De Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients suffering from intestinal nematodes (B82. 0) for 3 months or more 2) Age between 3 and 18 years 3) Patients of either sex, and transgender 4) Literate patients; ability to read English and/or Bengali or illiterate patient will be interviewed by the investigators maintaining adequate privacy to fill up the scale or questionnaires. 5) Providing written informed assent and/or consent voluntarily to participate in the trial. 6) The patient reporting to the OPD will be screened for the following symptom and the subject with minimum 5 of the following symptoms will be included in the study. a) Pain around the umbilics. b) Pruritus (itching or pain around anus) c) Hypopigmented patches in skin d) Pallor e) Nausea and vomiting f) Headache g) Gastric distension h) Loss of appetite i) Diarrhea j) History of passing intestinal nematodes in the stool

Exclusion criteria

Exclusion criteria: 1) Systemic complications due to intestinal nematodes infestation 2) Acute gastro enteritis 3) Amoebiasis 4) Acute abdomen (appendicitis) 5) Vulnerable population â?? unconscious, non-ambulatory, too sick for consultation, differently abled, terminally ill or critically ill patients, mentally incompetent people 6) Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure 7) Patients having the history of tobacco chewing and/or smoking, alcoholism and/or any other form(s) of substance abuse and/or dependence 8) Self-reported immune-compromised state 9) Already undergoing homeopathic treatment for chronic disease within last 1 month 10) Simultaneous participation in any other clinical trial

Design outcomes

Primary

MeasureTime frame
Number of patients with stool specimen positive for ova-parasites-cysts of intestinal nematodesTimepoint: Baseline, after 1 month and 3 months

Secondary

MeasureTime frame
Pediatric Quality of Life (PEDSQL) scoreTimepoint: Baseline, and every month, up to 3 months;Reducing symptoms - anal itching and discomfort, passing of gastrointestinal helminths in stool, abdominal pain, nausea, pallor, vomiting, diarrhea, anorexia, unusual irritability, weight loss, headache and pruritus skinTimepoint: Baseline, and every month, up to 3 months

Countries

India

Contacts

Public ContactSubhasish Ganguly

D N De Homoeopathic Medical College and Hospital

dr.subhasish67@gmail.com9007263548

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026